On May 9, 2019, Governor Newsom released a revised state budget proposal (known as the “May Revise”) focusing on health care, housing, early childhood, and education. The budget addressed his priorities for the “Healthcare for All” policy agenda, which includes expanding Medi-Cal coverage to young adults regardless of their immigration status.
Two bills sponsored by the organizations Physicians Committee for Responsible Medicine and Social Compassion in Legislation were defeated by CLSA and fellow research and education-focused stakeholders in recent weeks.
On Thursday, May 16, CLSA’s advocacy paid off when CMS released its final rule and fact sheet. In the final rule, CMS decided to not adopt two proposals which would have allowed Part D plans to exclude a protected class drug from their formularies for multiple years if price-growth exceeded an inflation index as well as if the drug represented a new formulation that is not a significant innovation over the original product.
On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes Assemblymember Rebecca Bauer-Kahan. We look forward to working with Assemblymember Bauer-Kahan and her team to advance policies that improve patient health and bring positive change for California patients and their families.
On Tuesday, May 7, CLSA hosted its annual Spring Reception and Dinner at the Folger Shakespeare Library on Capitol Hill to recognize and welcome the seven freshman members of the California Congressional Delegation.
On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes Congresswoman Katie Hill (D-Simi Valley). We look forward to working with Congresswoman Hill and her team to advance policies that improve patient health and bring positive change for California patients and their families.
CLSA today announced the appointment of Molly Fishman as Director of Federal Government Relations based in CLSA’s Washington, D.C. Office. Fishman joins CLSA following many years on Capitol Hill, where she most recently served as Legislative Director for U.S. Representative Jackie Speier.
On April 10, 2019, Reps. Ron Kind (D-Wisc.) and Jackie Walorski (R-Ind.) – together with Reps. Scott Peters (D-San Diego), Terri Sewell (D-Ala.), Suzan DelBene (D-Wash.), Darin LaHood (R-Ill.), Jason Smith (R-Mo.) and Rich Hudson (R-N.C.) – introduced legislation to permanently repeal the medical device excise tax, known as the Protect Medical Innovation Act of 2019 (H.R. 2207). CLSA is strongly supportive of this legislation and actively encouraged members of the California congressional delegation to lend their support as cosponsors.
On April 3, 2019, CLSA cohosted a multi-state life sciences association bipartisan congressional briefing on “Life Sciences Innovation: From Research to Cures.” The event was convened in collaboration with Rep. Scott Peters (D-San Diego) and Rep. John Curtis (R-Utah).
AB 1016 would establish a Rare Disease Advisory Council that would give patients a voice in state government and provide educational resources for elected leaders on critical issues related to access, coverage, and the diseases themselves.